Hammerstone Pro Trader

This Powerful Solution Allows You To Communicate & Collaborate In Real-Time Alongside Our Pro Data Stream

 

Get A Competitive Edge In Your Trading With The Hammerstone’s Unique Real-Time Data & Analysis

Our Platforms

What Is Hammerstone Pro Trader?

All our monthly plans come with a 14-day free trial and no fixed contract.

Hammerstone Pro Feed

The Hammerstone Pro Feed is our most powerful solution and a trusted resource that has been providing Wall Street with data since 2001. Using Symphony or other platforms, the Pro feed allows you to communicate and collaborate with other Pro traders in real-time to discuss intra-day news, markets and securities. The chat window allows you to see the news and chat stream simultaneously.

START A 14 DAY FREE TRIAL

Hammerstone Reports

Hammerstone Reports are expertly written daily updates sent 4 times per day directly to your inbox. These reports give you an in-depth analysis of earnings reports, street recommendations, economic data, sector news, market movers and more. Here are examples of the reports:

START A 14 DAY FREE TRIAL

Get Started With Hammerstone Pro For Free

Hammerstone Reports

4x Daily Reports

$50/mo

Start Your Free 14 Day Trial

  • Up-To-Date Reports (4x Daily)
  • News & In-Depth Analysis
  • Early Look Edition
  • Mid Morning Look Edition
  • Street Recommendations Edition
  • Daily Recap Edition
  • Delivery via Email
  • 14-Day Free Trial
  • Cancel Anytime

Start Your Free 14 Day Trial

Hammerstone Pro Trader

Get the Pro feed only

$299/mo
* Discounts Available For Multiple Licenses

Start Your Free 14 Day Trial

  • Strictly For The Professional Trader
  • Pro Trader Data Feed
  • Real Time Chat Alongside Data Feed
  • Pro Members Vetted To Maintain Chat Room Integrity
  • Filter functionality in data feed
  • Real-Time Breaking News With Context
  • Proprietary Research
  • Desktop & Mobile Compatible
  • 14-Day Free Trial
  • Cancel Anytime

Start Your Free 14 Day Trial

COMPLETE PRO TRADER PACKAGE

Pro Trader Data Feed + 4X Daily Reports

$329/mo
* Discounts Available For Multiple Licenses

Start Your Free 14 Day Trial

  • All Features of Pro Data Feed & Reports
  • Real Time Chat Alongside Data Feed
  • Pro Members Vetted To Maintain Chat Room Integrity
  • Real-Time Breaking News With Context
  • Actionable Ideas, Running Commentary
  • Earnings Releases & Interpretation
  • Proprietary Research & Index Levels
  • Delivery via Web App (No Install Required)
  • 4x Daily Editions Of Hammerstone Reports
  • Desktop & Mobile Compatible
  • 14-Day Free Trial
  • Cancel Anytime

Start Your Free 14 Day Trial

No obligations, no contracts, cancel at any time, 100% risk free.

Here’s Yesterday’s Market Pro Sample Feed

Please Note: This Is A Delayed Example (without the Chat Room), Not The Live Feed.

  • Posted At: 17:21:41 | 05-24-2019

    At week's end, the Dow Industrial Average declined for a 5th straight weekly loss (hasn't lost 5-straight weeks since 2011 according to CNBC), while the S&P 500 and Nasdaq Comp post their third straight weekly decline. Utilities rallied for another all-time high, while software stocks slipped after results from ADSK and SPLK weighed on the sector and transports fell for the 5th time in six sessions.

  • Posted At: 17:15:08 | 05-24-2019

    $TBIO 5.58M share offering

  • Posted At: 17:11:04 | 05-24-2019

    $SPY top S&P decliners on the day: $FL -16%, $ADSK -4.9%, $BHGE -3.6%, $STZ -3.6%, $QCOM -3% and $HAL -2.3% top S&P 500 gainers - $TSS +13%, $INTU +6.7%, $CTL +4.6%, $HPQ +4.3%, $GPN +3%, $WAB +3.3%

  • Posted At: 17:05:34 | 05-24-2019

    $MYOV MYOVANT SCIENCES PROVIDES CORPORATE UPDATES AND REPORTS FINANCIAL RESULTS FOR FOURTH FISCAL QUARTER AND FULL FISCAL YEAR ENDED MARCH 31, 2019 MYOVANT SCIENCES LTD MYOV.N Q4 SHR LOSS $1.07 MYOVANT SCIENCES LTD MYOV.N Q4 SHR ESTIMATE $-1.02 -- REFINITIV IBES DATA MYOVANT SCIENCES LTD - DATA FROM FOUR ADDITIONAL PHASE 3 CLINICAL STUDIES EXPECTED OVER NEXT THREE QUARTERS

  • Posted At: 17:00:57 | 05-24-2019

    $PFE Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint. Treatment with LYRICA did not result in a statistically significant reduction in seizure frequency versus placebo. Lyrica is not indicated in any population for the treatment of PGTC seizures. The study was a post-marketing commitment to the U.S. Food and Drug Administration (FDA) - more $PFE

  • Posted At: 16:56:58 | 05-24-2019

    $IMMR puts active

  • Posted At: 16:45:14 | 05-24-2019

    $TMUS $S Charles Gasparino @CGasparino [email protected] - @sprint officials expect DOJ to demand more concessions as merger discussions heat up; Company officials say DOJ Antitrust chief Makan Delrahim has yet to state his intentions on merger more now @FoxBusiness @LizClaman $TMUS $S

  • Posted At: 16:31:56 | 05-24-2019

    https://nypost.com/2019/05/24/fcc-and-doj-may-agree-on-sprint-t-mobile-merger

  • Posted At: 16:29:26 | 05-24-2019

    $S $TMUS FCC and DOJ may agree on Sprint, T-Mobile merger - NY Post https://nypost.com/2019/05/24/fcc-and-doj-may-agree-on-sprint-t-mobile-merger/

  • Posted At: 16:26:19 | 05-24-2019

    $ONCE shares quick spike higher, then right back in.up about 0.8% (traded to highs of $111.73 briefly) - ***recall on 5/14 - Roche (RHHBY) and Spark Therapeutics (ONCE) announced that Roche and Spark intend to refile on or about May 23 their respective Premerger Notification and Report Forms under the Hart-Scott-Rodino Act in connection with Roche's pending acquisition of Spark pursuant to its previously announced tender offer to purchase all of the outstanding shares of common stock of Spark for $114.50 per Share (fwiw) (context) - Roche/ONCE deal was announced on 2/25/19

  • Posted At: 16:08:41 | 05-24-2019

    $TLT - Treasury prices with a little give back today as stocks bounce, but overall a solid week with yields falling across the board. After falling yesterday to their lowest levels since late 2017, the 10-yearTreasury yield inched higher to around 2.32% (now down about 7 bps on the week). Meanwhile, the 2-year yield rose about 3.5 bps to 2.165%, its biggest move in about 6-weeks (down about 4 bps on the week) and the 30-yr yield is at 2.75% (down about 7 bps on the week)

  • Posted At: 15:56:03 | 05-24-2019

    $MRVL *MARVELL TECHNOLOGY OUTLOOK TO POSITIVE FROM STABLE BY FITCH

  • Posted At: 15:48:02 | 05-24-2019

    $UNH +70bps, testing top of intraday trading range

  • Posted At: 15:39:06 | 05-24-2019

    $CIR $CR *GABELLI FIRM OWNS ABOUT 15% OF CIRCOR SHARES

  • Posted At: 15:33:47 | 05-24-2019

    *NYMEX WTI CRUDE JUL. FUTURES SETTLE AT $58.63 A BARREL *NYMEX GASOLINE JUN. FUTURES SETTLE AT $1.9345 A GALLON *NYMEX DIESEL JUN. FUTURES SETTLE AT $1.9713 A GALLON

Get Started With Hammerstone Pro For Free

Hammerstone Reports

4X Daily Reports

$50/mo

Start Your Free 14 Day Trial

Hammerstone Pro Trader

Get the Pro feed only

$299/mo
* Discounts Available For Multiple Licenses

Start Your Free 14 Day Trial

COMPLETE PRO TRADER PACKAGE

Pro Trader Data Feed + 4x Daily Reports

$329/mo
* Discounts Available For Multiple Licenses

Start Your Free 14 Day Trial

No obligations, no contracts, cancel at any time, 100% risk free.

Witness Hammerstone Markets In Action

CASE STUDY: $WDAY
(Workday, Inc.)

case study

Chart was created on Bloomberg Terminal
 

On April 10, 2019, after the markets opened, Keybanc Capital Markets published a note on Workday, Inc. ($WDAY), an ondemand financial management company, detailing how $WDAY had won a contract with Berkshire Hathaway’s GEICO insurance division with the potential to spark big sales momentum in their cloud finance systems.

Through Hammerstone’s many sources and contacts across Wall Street, we were alerted to the Piper $WDAY news immediately and  disseminated it to our clients while $WDAY was still in negative territory, starting its rally seconds later.  Additionally, Hammerstone was able to also provide its users with a summary of the $WDAY piece by Piper within 7 minutes.  Later, at 10:45, Hammerstone noted that $WDAY had continued rallying, now up 2.6%, making new highs of the day (and, by chance, the actual high of the day), thus, making sure we kept our subscribers in the loop on a stock that was still moving significantly.


CASE STUDY: $BHVN
(Biohaven Pharma)

case study

Chart was created on Bloomberg Terminal
 

Hammerstone’s job as a financial news aggregator is to find our clients potentially market moving headlines from sources that run the gamut from mainstream outlets such as Bloomberg and Reuters, etc., to smaller specialized news providers and social media.   In the case of Biohaven Pharma ($BHVN), Hammerstone relayed a breaking $BHVN headline from Bloomberg News within seconds to our subscribers besting our competitors by 1 to 5 minutes in a display of Hammerstone’s speed.

Furthermore, Hammerstone followed up the headline less than 2 minutes later with context, using our database to add  the summary of a Piper Jaffray note from Feb. 1 that named $BHVN as a possible takeover candidate for deal hungry Amgen Inc. ($AMGN).  More context was added at 11:35 when Hammerstone informed its subscribers that both Allergan Inc. ($AGN) and Johnson & Johnson ($JNJ)  manufacture drugs in the same field as $BHVN.

In this case, Hammerstone was able to spot a breaking headline from a crowded news source, relay it quickly and provide color (2 posts on $BHVN’s % move up) and convey 2 pieces of context to our subscribers, all within 4 minutes of the breaking story.


CASE STUDY: $IRTC
(Irhythm Technologies, Inc.)

case study

Chart was created on Bloomberg Terminal
 

$IRTC (Irhythm Technologies, Inc.)– During an Apple, Inc. ($APPL) presentation, we noted early that $APPL was entering the digital health market, where $IRTC is the dominant player. Soon after, the stock preceded to move lower as more traders recognized the same theme we identified (Apple moving into the this sector was negative for them).


CASE STUDY: $SFLY
(Shutterfly, Inc.)

case study

Chart was created on Bloomberg Terminal
 

$SFLY (Shutterfly, Inc.)– Hammerstone was quick with analysis after Amazon had released a new product which would be direct a competitor to Shutterfly. After listing the Amazon price points on the product, we noted technical levels as $SFLY proceeded to drop 10%.


CASE STUDY: $SYF
(Synchrony Financial)

case study

Chart was created on Bloomberg Terminal
 

$SYF (Synchrony Financial)– This chart highlights our ability to pull up past broker comments/research related to breaking news.

As Walmart, Inc ($WMT) headlines crossed the tape about possibly ending its partnership with $SYF, Hammerstone was able to add context and quantify our news flow by describing exactly how valuable that loss could be to $SYF.

This allowed our clients to make educated trading decisions within seconds of the breaking news as the street realized how detrimental this might be to $SYF.


CASE STUDY: $MAXR
(Maxar Technologies, Ltd.)

case study

Chart was created on Bloomberg Terminal
 

$MAXR (Maxar Technologies, Ltd.) – The Hammerstone Market Feed does an excellent job aggregating data/flow from many different sources.

Here, we immediately disseminated a short report on $MAXR as it was released while highlighting the important data points in the report.

By being relaying this information quickly, our clients were able to take early advantage in $MAXR before the price deterioration in the stock.


CASE STUDY: $VERI
(Veritone, Inc.)

case study

Chart was created on Bloomberg Terminal
 

$VERI (Veritone, Inc.)– $VERI is an example of how Hammerstone adds idea generation with our curation.

$VERI stock rose from below $10 to above $70 in short period of time. Hammerstone quickly realized a potential disconnect in valuation between $ACTG(Acacia Research, Corp)/$VERI and, more importantly, the fact $ACTG owned 4 million shares of $VERI.

We noted a likelihood of $ACTG liquidating their position after the rapid price appreciation of $VERI. Hammerstone early in our analysis and well ahead of other services and news outlets (noted on chart) as stock dropped 35% intraday.